INTRODUCTION
Flax (Linum usitatissimum), also known as common flax or linseed consists of the dried fully ripe seeds of the genus Linum belonging to family Linaceae 1 . Chemically, it contains d-galacturonic acid, l-rhamnose, l-galactose, and dxylose. It is gluten free and also rich in omega-3, omega-6, α-linolenic acid, lignans, high quality proteins and fibers. The flax seed mucilage has been widely ABSTRACT The aim of this study is to prepare flaxseed mucilage (FSM) and chitosan polyelectrolyte complex (PEC) nanoparticles by ionic gelation method for developing sustained release formulation. For the formation of PEC nanoparticles, the water extract of flax seed is obtained by soaking the seeds in water overnight followed by precipitation with ethanol and washing with distilled water.FSM was interacted with fully protonated chitosan (in acetic acid 2% v/v) using Isonicotinylhydrazide (INH) as a model drug. The results of optimization study reveals that lower level of chitosan and flaxseed mucilage favors the lowest particle size.The optimum quantum of FSM and chitosan were found to be 0.011% (w/v) and 0.011% (w/v) respectively, that produced nanometric particles of size 326 nm with poly-dispersity index (PdI) of 0.217.The in vitro release profile of INH from the optimized batch was determined using the dialysis sac and it was found that INH get released over a prolonged period of 20 hours following Higuchi's square root release kinetics with the combination of diffusion and erosion of matrix as release mechanism. It can be concluded from the present study that interaction between chitosan and FSM can be used for the formation of PEC nanoparticles and for developing sustained release formulation. explored in traditional herbal remedies, food and pharmaceutical industry. Flaxseed is a multi component system containing biologically-active plant substances like dietary fiber, oil, protein, soluble polysaccharides, phenolic compounds, minerals, vitamins and lignans 2 . It also contains water soluble and insoluble fibers. Insoluble fibers help in improving laxation and preventing constipation, chiefly by increasing fecal mass and lowering bowel transit time 3 . Moreover, water-soluble fibers helps in maintaining glucose levels and lowering the cholesterol levels in blood 4 . Flax lignans is known to be effective in reducing the growth of particularly hormone sensitive cancerous tumors, such as those of the breast, endometrium and prostate 5 . Flaxseeds were also used as medicines since immemorial times to relieve the abdominal pain and as cough remedy. Flaxseeds possess significant health benefits besides the nutrition due to high content of ω-3 α-linolenic acid and of lignans having antioxidant properties 2 .
Chitosan (CS) is commonly obtained from deacetylated (D-glucosamine) derivative of chitin, a cationic polysaccharide. It has already been explored for formulating nanoparticles with polyanions by ionotropic gelation method 6 . The complexes of chitosan with polyanions have been screened in effectively limiting the release of entrapped drug as compared to the polyanion or chitosan alone. PEC nanoparticles of chitosan with psyllium arabinoxylan 7 , hyaluronic acid 8 , carboxymethyl gum kondagogu 9 , carboxymethyl amylopectin 10 , gum ghatti 11 and sodium alginate 12 have been reported in literature. Isonicotinylhydrazide (INH) is an antibiotic that is used in the treatment of tuberculosis 13 . It is used in combination with other tuberculosis drugs to prevent the development of drug resistance and also act as bactericidal and bacteriostatic drug. It also acts as a source of free radicals by inhibiting the cytochrome P450 system. The solubility of INH in water is 125mg/ml at room temp. It is on the border line of BCS Class I &III 14 . In this piece of research work PEC nanoparticles of CS-FSM were prepared by ionotropic gelation method using INH as a model drug. The PEC nanoparticles was characterized by fourier-transform infra-red spectroscopy, X-ray diffraction analysis, thermo gravimetric analysis and scanning electron microscopy. The interaction of Chitosan-FSM in preparing PEC nanoparticles was optimized by using two-factor, three-level central composite experimental design. In-vitro release behaviour of drug INH from the optimised batch of PEC nanoparticles was evaluated by release rate study.
METHODOLOGY
Flax seeds were purchased from Patanjali mega store, Hisar, India. Chitosan was purchased from Sisco Research Laboratories Pvt. Ltd. Mumbai, India. Isonicotinylhydrazide (INH) was generously provided as a gift sample from Aventis Pharma Ltd (Ankleshwar, India). All other chemicals like ethanol and acetic acid (SD Fine Chemical Ltd.) used in this study were of analytical grade and utilised as received.
Isolation of flaxseed mucilage
The water extract of flax seed was obtained by soaking the seeds in distilled water (1:50) overnight. The insoluble fraction was removed by passing it through the muslin cloth. To isolate the mucilage, equal volume of ethanol was added for precipitation under continuous stirring. The separated mucilage is then washed with distilled water and collected through filtration by muslin cloth. The mucilage so obtained was kept at -80 o C for 4 h followed by lyophilization in a laboratory model freeze drier at -90 o C under a pressure of 0.0010 mbar for 24 h.
Preparation of flaxseed mucilage-chitosan PEC nanoparticles
FSM was interacted with fully protonated chitosan (in acetic acid 2% v/v) using INH as a model drug for the preparation of PEC nanoparticles. Aqueous chitosan solutions were prepared in acetic acid (2% w/v) under stirring while aqueous solutions of FSM were prepared by adding the required quantity of FSM as per the design protocol in distilled water followed by stirring. The polyelectrolyte complex nanoparticles of FSM-CS were prepared by drop wise addition of aqueous solution of CS (0.010 to 0.020% w/v) containing INH (50 % of the total polymer weight) to the aqueous solution of FSM (0.010 to 0.020% w/v) under strong agitation at room temperature 7 .
Experimental design
The preparation of FSM-CS polyelectrolyte nanoparticles was optimised using 2-factor,3-level central composite experimental design (Table I) . It was discerned from the preliminary trials that concentration of FSM and CS affect the p-size, polydispersity index (PdI) and entrapment efficiency. Therefore, the concentration of chitosan (X 1 ) and FSM (X 2 ) were taken as the formulation variables whereas particle size (Y 1 ) , PdI (Y 2 ) and entrapment efficiency (Y 3 ) were selected as response variables. Each of the independent variable was investigated at three levels (i.e. −1, 0, +1). Design Expert software (Version 11.0) was used for the experimental design and statistical analysis of data 7 . 
Characterization of flaxseed mucilage and chitosan PEC nanoparticles:
The polyelectrolyte complex nanoparticles of flaxseed mucilage-chitosan containing INH drug were characterised by Fourier transform infra-red spectroscopy (FT-IR), Differential scanning calorimeter (DSC), Powder X-ray diffraction analysis (PXRD) and Scanning electron microscopy (SEM) studies and further evaluated for particle size (d, nm), polydispersity index (PdI), and drug entrapment efficiency.
Particle size analysis
Average particle size and polydispersity index (PdI) of nanoparticles was measured by using Zetasizer (Nano ZS90, Malvern Instrument, UK). The measurements were done in automated mode at 25°C after equilibrating for 120 s.
Entrapment efficiency
The amount of drug entrapped in nanoparticles was calculated by separating the unentrapped drug by centrifuging the sample at 15000 rpm for 40 min by cooling centrifuge (C-24 BL, Remi Instruments, and Mumbai, India). The supernatant was analyzed for the contents of unentrapped INH by measuring the absorbance at 262 nm in a UV-Vis spectrophotometer (Cary 5000, Varian Australia). The entrapment efficiency (%) was calculated as follows:
Where, INH t is the total amount of isoniazid used in the preparation of polyelectrolyte complex nanoparticles and INHs is the unentrapped isoniazid present in the supernatant.
Fourier transform infra-red spectroscopy (FT-IR)
FSM-CS PEC nanoparticles were subjected to FT-IR spectroscopy in a FTIR spectrophotometer (Perkin-Elmer, Spectrum, US) in range of 4000cm -1 to 400 cm -1 using KBr pellet method, to detect interaction between drug and polymer.
Powder X-ray diffraction analysis (PXRD)
Powder X-ray diffraction analysis was carried out to study the structure, composition and physical properties of samples. The CS, FSM, INH and PEC powder samples were examined using an X-ray diffractometer (Miniflex 2, Rigaku, Japan) from 0 • to 80 • diffraction angle (2Ɵ) range under the following measurement conditions: source, nickel filtered Cu-K α radiation; voltage 30 kV; current 25 mA; scan speed 0.05 min−1, division slit 1.25•, receiving slit 0.3 mm.
Differential scanning calorimeter
Differential scanning calorimetric analysis was carried out to confirm the physical state and purity of the samples. The DSC of CS, FSM, INH and PEC were carried out in the temp. range of 25°C to 250°C under constant nitrogen purge of 100ml/min with heating rate of 10°C per minute using DSC (Perkin Elmer USA).
Scanning electron microscopy
The surface and shape of the polyelectrolyte complex was examined using scanning electron microscopy. The sample was mounted using double sided adhesive tape on metal grids and coated with gold under vacuum prior to observation.
In-vitro drug release study
The drug release from the optimized batch formulation and drug solution was determined using dialysis sac method using USP-II dissolution apparatus. An accurately measured volume of nanoparticles (5ml) and equivalent amount of drug solution were placed in the dialysis tubing (cut off 10,000 kDa) separately. The dialysis tubing was tied up to the paddle of USP type II dissolution apparatus (TDL-08L, Electro lab, India) and immersed in 300 ml of dissolution fluid (phosphate buffer pH 7.4). The temp. of dissolution media was maintained at 37 • C ± 0.5 • C with continuous stirring at 50 rpm. An aliquot of 5 ml sample was withdrawn at various time intervals and the media volume was maintained by replacing equal volumes of fresh media i.e. buffer pH 7.4. The concentration of INH in the samples was determined in UV-visible spectrophotometer by measuring absorbance at 262 nm. The release data was then fitted into various release kinetic models to estimate the kinetic and mechanism of release.
RESULTS AND DISCUSSION
CS-FSM PEC nanoparticles prepared by ionic gelation method were optimized using 2-factor,3-level central composite design (Design expert version 11.0) and characterized by FTIR, DSC, XRD and SEM studies. The in-vitro release pattern of optimized batch was estimated using USP type II dissolution apparatus using dialysis sac. Figure 1 exhibits the FT-IR spectra of PEC, CS, INH, and FSM respectively in the frequency range of 4000-400cm -1 . The spectra of CS show a broad absorption band at 3422.04 cm -1 which may be attributed to -OH stretching of alcohols. The peak appearing at 2874.61 cm -1 can be ascribed to -CH stretch of alkanes, while the peak at 2145.70 cm -1 is due to -C≡C− stretch of alkynes, whereas peak at 1602.93cm -1 is due to -NH bending whereas peaks at 1420.62 cm -1 and 1384.11cm -1 are due to -CH bending of alkanes. The spectra of FSM exhibit a broad absorption band at 3423.63 cm -1 is due to -OH stretching of alcohols. The peak appearing at 2933cm -1 is due to -CH stretching of alkane, while the peaks appearing at 2345.45 cm -1 and 2364.71 cm -1 may be ascribed to -CH stretch of alkane. The peaks at 1618.03 cm -1 and 1420.42 cm -1 are due to -NH bending and -CH bending, respectively. The spectra of pure drug INH shows a sharp absorption peak at 3304.06 cm -1 due to presence of (-NH 2 ) amine group and other peak at 3114.02 cm -1 is due to -NH stretch of amine group and other peak -CH on 2862.74 cm -1 , -C=O stretch on 1666.53 cm -1 , -NH bending on 1602.55 cm -1 and 1556.24 cm -1 shows presence of amide group. Peak at 1411.93 cm -1 shows -CH bending of alkane, while peak at 1334.23 cm -1 , 1221.32 cm -1 and 1141.62 cm -1 are due to -CN stretch of amine. The spectra of CS-FSM PEC displayed characteristic peak of drug at 1648 cm -1 that is attributed to amide carbonyl structure of hydrazide in PEC and the peak appearing at1087.02cm -1 may be ascribed to -CN stretch of amine whereas peak appearing at 1024.20 cm -1 is due to -C-O stretch of ether. The peaks at 889.87 cm -1 and 672.51 cm -1 are due to =C-H bending of alkene appeared in PEC. The spectra of CS-FSM polyelectrolyte complex demonstrated a slight shift of the peak at 3292.27cm -1 due to interaction between drug INH and carriers that confirms the formation of complex. There is a disappearance of broad endotherm and a shift in the endothermic peak with decreased intensity is noticed that indicates that modification has been taken place in the formation of electrolyte complex. Impact of critical process parameter and critical material attributes on the average particle size, PdI and entrapment efficiency of PEC nanoparticles between the FSM and CS was optimized for the formation of nanometric polyelectrolyte complex. The preliminary trial data suggested that concentration of chitosan and flax seed gum influence the p-size of polyelectrolyte particles and PdI. Accordingly, the concentration of chitosan (X 1 ) and FSM (X 2 ) were chosen as formulation variables whereas p-size (Y 1 ), PdI (Y 2 ) and entrapment efficiency (Y 3 ) were fixed as response variables to optimize the preparation of polyelectrolyte particles with constraints of minimum p-size and PdI and maximum entrapment efficiency of drug. Table 1 shows the result of PS(Y 1 ), PdI(Y 2 ) and EE (Y 3 ) of PEC nanoparticles prepared as per the design protocol. The response data was fitted into various polynomial models using the experimental design. It was discovered that the responses PdI (Y 2 ) and entrapment efficiency (Y 3 ) were fitted best into linear model with none transformation while the response p-size (Y 1 ), was fitted best in to linear response surface model with square root transformation.
The polynomial models for the responses Y 1 ,Y 2 and Y 3 can be expressed by the equation:
The results of ANOVA are summarised in Table II . The polynomial model was found to be significant (P<0.0500) with non-significant lack of fit (P>0.05).
The correlation between the experimental and predicted response is determined by the value of R 2 (>0.8). This value indicated good correlation between the experimental and predicted response. The measurement of signal to noise ratio i.e. adequate precision is much above the required value of 4 indicating the adequate signal and lend the model fit to navigate the design space. , respectively. It can be deduced from the plot that a linear relationship exists between dependent and independent variables. It is also observed from the plot that lower concentration of CS and FSM favors the lower particle size with more prominent effect of concentration of CS. This may be described by the fact that higher concentration of CS increases the viscosity of CS dispersion thus resulting in increased droplet size on spraying chitosan on FSM solution and thereby leading to increase in size of polyelectrolyte complex particles. The nanoparticulate preparation provided a prolonged release of INH with approximate 98% of drug released in a period of 20h. The limiting effect of dialysis membrane was studied by comparing the release behavior of nanoparticulate system with equivalent concentration of drug solution that showed more than 90 % release in less than 5 h. The release of INH from nanoparticulate system and from drug solution was fitted into various kinetic models to estimate their kinetics and mechanism of release mechanism (Table 3) . The outcomes of release rate data of the formulations were found to be fitted best into Higuchi model (with R 2 =0.9658) of release kinetics. Further the value of 'n' is 0.4512 (0.43<n<0.85), the release exponent of korsemeyer and Peppas equation, indicated that the release of INH from nanoparticulate system occurs by diffusion and erosion mechanism from the matrix.
The interaction between cationic CS and anionic FSG was used to formulate polyelectrolyte complex. The DSC and XRD studies confirm the crystallinity of the product. The optimization study showed that lower level of chitosan (0.011%) and flaxseed gum (0.011%) favors the minimum particle size with more prominent effect of concentration of chitosan. The release of drug INH from PEC nanoparticles occurred over a prolonged period of time following Higuchi square root kinetics model and release occurs by mechanism of diffusion and erosion from the matrix. It can be concluded from the present study that interaction between chitosan and FSG can be used for the formation of PEC nanoparticles and for developing sustained release formulation.
